Insulin pumps effective for children with diabetes

Pre-school youngsters with type I diabetes can be treated as successfully with insulin pumps as with daily injections, researchers at the Indiana University School of Medicine report.

A clinical trial at the Riley Hospital for Children studied 20 patients 5 years old or younger receiving treatment with continuous insulin infusion by pump and 17 who were receiving injection therapy. Physicians compared control of blood sugar levels, parents' satisfaction and safety in both groups.

"Pump therapy was safe and well tolerated," says endocrinologist Linda A. DiMeglio, M.D., who led the study. "This therapy in preschool-aged children was not associated with clinically significantly differences in glycemic control compared to intensive injection therapy."

Parents were satisfied with the pumps; 95 percent of families continued use of the device after the six-month study was completed.

"It remains to be seen whether the benefit of insulin pump therapy in terms of flexibility and convenience justify the increased costs for very young children with diabetes," Dr. DiMeglio says. "Studies of long-term outcomes of children started on pump therapy at very young ages also are needed."

Type 1 diabetes, also called juvenile diabetes, is usually diagnosed in children and young adults. With type I diabetes, the body does not produce the insulin which is necessary for the body to be able to metabolize sugar.

The IU study's findings appeared in the Journal of Pediatrics.

http://medicine.indiana.edu

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A novel approach to prevent severe liver disease in diabetes